WiseGuyReports have announced the addition of a new report titled “Biotechnology – Global Market Outlook (2017-2026)”.
Biotechnology is a set of tools that uses living organisms to make or modify a product, improve plants, trees or animals, or develop microorganisms for specific uses. It is a combination of various technologies, applied together to living cells, including not only biology, but also subjects like mathematics, physics, chemistry and engineering.
Factor such as growing demand for agro-based products, reducing cost of DNA sequencing, rising prevalence of chronic disorder are driving the market growth. However, ethical issues associated with clinical trials and risks associated with GM organisms and crops are restraining the market growth.
By Technology, Nanobiotechnology is expected to dominate the market. Various drug delivery therapies use nanobiotechnology for chronic disorders such as cancer. It involves the advancement of nanoparticle based gold nanoparticles, chemotherapeutic drugs, and quantum dots for molecular diagnosis and nanobiosensors which help in drug delivery and optical imaging. North America accounted for largest market share attributed to the increase in investments in R&D pertaining to new drug discovery.
Some of the key players in the Biotechnology market include Gilead, Biogen, Celgene Corporation, AstraZeneca, Abbott Laboratories, Novo Nordisk A/S, Novartis AG, Lonza, Amgen, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Pfizer, Inc., Sanofi Aventis, Merck & Co, Roche and Genentech.
View Detailed Report at https://www.wiseguyreports.com/reports/3068744-biotechnology-global-market-outlook-2017-2026
Technologies Covered:
- DNA Sequencing
- Fermentation
- Cell Based Assay
- Nanobiotechnology
- Chromatography
- PCR Technology
- Tissue engineering and Regeneration
- Other Technologies
Applications Covered:
- Industrial Processing
- Bioinformatics
- Food & Agriculture
- Health
- Natural Resources & Environment
- Other Applications
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Argentina
o Brazil
o Chile
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Request Sample Report at https://www.wiseguyreports.com/sample-request/3068744-biotechnology-global-market-outlook-2017-2026
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Biotechnology Market, By Technology
6 Global Biotechnology Market, By Application
7 Global Biotechnology Market, By Geography
8 Key Developments
11 Company Profiling
11.1 Gilead
11.2 Biogen
11.3 Celgene CORPORATION
11.4 AstraZeneca
11.5 Abbott Laboratories
11.6 Novo Nordisk A/S
11.7 Novartis AG
11.8 Lonza
11.9 Amgen, Inc.
11.10 F. Hoffmann-La Roche Ltd
11.11 Johnson & Johnson Services, Inc.
11.12 Pfizer, Inc.
11.13 Sanofi Aventis
11.14 Merck & Co
11.15 Roche
11.16 Genentech
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
